Literature DB >> 16760110

Occlusion treatment for amblyopia: assessing the performance of the electronic occlusion dose monitor.

Maria Fronius1, Yaroslava Chopovska, Julia Nolden, Sjoukje E Loudon, Marc Lüchtenberg, Alina Zubcov, Larisa Pepler.   

Abstract

Electronic Occlusion Dose Monitors (ODMs) are a fairly recent development. As part of the international Electronic Recording of Patching for Amblyopia Group (ERPAG), we are the first center in Germany to apply these devices. The aim of our independent study was a further assessment of their potential, including technical features and the practicability of long-term use under near-clinical conditions. The ODMs, taped to the occlusion patch, measure the temperature difference between the surface of the eye and the surroundings. Investigators and patients' families kept occlusion diaries while using ODMs. Measurements were performed on the eye (patch tight or detached), forehead, arm and in trouser pockets, and while varying the room temperature. Patients' occlusion was monitored for several months together with acuity development. ODM acceptance was assessed by questionnaire. Written and monitored occlusion times corresponded excellently. Proper measurements on the eye could be distinguished more readily from those with the patch detached or in the pocket than from measurements on the arm and forehead. Very high temperatures (33-37 degrees C) prevented reliable measurements. Using ODMs was convenient for parents but time-consuming for researchers. Despite occasional data loss (incomplete diaries, ODM failure), acuity development could be followed as a function of monitored occlusion dose. This study contributes to the specification of the ODM features and their refinement for clinical use.

Entities:  

Mesh:

Year:  2006        PMID: 16760110     DOI: 10.1080/09273970600700962

Source DB:  PubMed          Journal:  Strabismus        ISSN: 0927-3972


  12 in total

Review 1.  [The latest on amblyopia treatment].

Authors:  O Ehrt
Journal:  Ophthalmologe       Date:  2008-05       Impact factor: 1.059

Review 2.  [Treatment monitoring and innovations in amblyopia treatment].

Authors:  Kai Januschowski; Caroline Emmerich; Annegret Abaza; Henrike Julich-Haertel; Annekatrin Rickmann
Journal:  Ophthalmologe       Date:  2019-12       Impact factor: 1.059

3.  A morphological study of amblyopic eyes in children failing to achieve normal visual acuity after electronically monitored long-term occlusion treatment.

Authors:  Claudia Kuhli-Hattenbach; Michael Janusz Koss; Thomas Kohnen; Maria Fronius
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-06-23       Impact factor: 3.117

4.  Randomised comparison of three tools for improving compliance with occlusion therapy: an educational cartoon story, a reward calendar, and an information leaflet for parents.

Authors:  A M Tjiam; G Holtslag; H M Van Minderhout; B Simonsz-Tóth; M H L Vermeulen-Jong; G J J M Borsboom; S E Loudon; H J Simonsz
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-07-22       Impact factor: 3.117

5.  Monitoring of wearing and occlusion times with smart shutter glasses-A proof of concept.

Authors:  Frank R Ihmig; Kai Januschowski; Timo Koch; Thomas Velten; Annekatrin Rickmann
Journal:  PLoS One       Date:  2022-06-24       Impact factor: 3.752

6.  Objective measurement of spectacle wear with a temperature sensor data logger.

Authors:  Matthew J Lentsch; Jason D Marsack; Heather A Anderson
Journal:  Ophthalmic Physiol Opt       Date:  2017-11-08       Impact factor: 3.117

7.  Improved monitoring of adherence with patching treatment using a microsensor and Eye Patch Assistant.

Authors:  Jingyun Wang; Hongxin Xu; Bryan De La Cruz; Sarah E Morale; Reed M Jost; David A Leske; Jonathan M Holmes; Eileen E Birch
Journal:  J AAPOS       Date:  2020-03-18       Impact factor: 1.220

8.  Electronic monitoring of occlusion treatment for amblyopia in patients aged 7 to 16 years.

Authors:  Maria Fronius; Iris Bachert; Marc Lüchtenberg
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-05-05       Impact factor: 3.117

9.  Objective Monitoring of Spectacle Wearing Times in Adult Subjects Using the Theramon® Thermosensor.

Authors:  Annegret Abaza; Gideon Wahl; Constanze Kortüm; Kai Januschowski; Dorothea Besch; Charlotte Schramm
Journal:  Clin Ophthalmol       Date:  2021-03-31

10.  Assessment of Adherence to Visual Correction and Occlusion Therapy in the Infant Aphakia Treatment Study.

Authors:  Carolyn Drews-Botsch; George Cotsonis; Marianne Celano; Scott R Lambert
Journal:  Contemp Clin Trials Commun       Date:  2016-05-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.